Publications

The Health Technology Assessment Consumer Consultative Committee (HTACCC) met on 19 February 2021 for its 14th formal meeting. This document provides a record of the meeting.

This presentation, delivered on 3 March 2022, contains an update to Australia's COVID-19 vaccine rollout.

This data file contains statistical data about Australia's COVID-19 vaccinations.

This social tile, in English, explains how to use a rapid antigen oral saliva test.

This social tile, in English, explains how to use a nasal swab rapid antigen test.

This alert contains updates for disability service providers about the COVID-19 vaccination rollout.

This document gives feedback for applicants of the PRIMM round 2 grant opportunity, which is overseen by the Office of the National Rural Health Commissioner.

This presentation, delivered on 2 March 2022, contains an update to Australia's COVID-19 vaccine rollout.

This data file contains statistical data about Australia's COVID-19 vaccinations.

This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 1 March 2022

This data file contains statistical data about Australia's COVID-19 vaccinations.

This infographic issued on 1 March 2022 provides a weekly traffic light report of the coronavirus (COVID-19) situation across Australia.

This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 28 February 2022

This presentation, delivered on 1 March 2022, contains an update to Australia's COVID-19 vaccine rollout.

This report outlines the evaluation of evidence on the clinical effectiveness of Rolfing as part of the Natural Therapies Review 2024.

The national guidance provides a framework to identify workers exposed to respirable crystalline silica dust and support medical practitioners carry out health surveillance within their specific training and experience. 

The document summarises the national guidance for doctors assessing workers exposed to respirable crystalline silica dust.

This practice guide provides medical practitioners with guidance on identifying and assessing workers exposed to respirable crystalline silica dust, and carrying out health assessments and surveillance. 

This exposure risk matrix assists medical practitioners assess workers exposed to respirable crystalline silica dust.

This decision aid helps patients exposed to respirable crystalline silica (RCB) dust decide their next steps, including if they should keep working.

This questionnaire helps general practitioners assess workers exposed to respirable crystalline silica dust.

This scale helps general practitioners assess workers exposed to respirable crystalline silica dust.

This case study shows how to appropriately determine a change in spirometry over time in an individual exposed to respirable crystalline silica dust.

This administrative report outlines how the National Dust Disease Taskforce developed national guidance for doctors assessing workers exposed to respirable crystalline silica dust.

The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for human immunodeficiency virus.